Reactive Cutaneous Capillary Endothelial Proliferation Caused by Camrelizumab: Sixteen Case Reports

To investigate the regularity and characteristics of adverse drug reaction (ADR) of reactive cutaneous capillary endothelial proliferation caused by Camrelizumab, so as to provide reference for clinical rational use of drugs. Searching for case reports of Camrelizumab-induced reactive cutaneous capi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hui-Mei, Pang, Guang-Ming, Huang, Xiao-Ling, Qin, Hong-Liang, Zhang, Si-Jun, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389131/
https://www.ncbi.nlm.nih.gov/pubmed/37529461
http://dx.doi.org/10.4103/ijd.ijd_343_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389131/
https://www.ncbi.nlm.nih.gov/pubmed/37529461
http://dx.doi.org/10.4103/ijd.ijd_343_22

Ejemplares similares